I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Evaluation of hepatitis serology and frequency of viral rea..:
Yazıcı, A
;
Şahin, N
;
Capkin, E
...
Rheumatology International. , 2023
Link:
https://hdl.handle.net/11499/52937
RT Journal T1
Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study
UL https://suche.suub.uni-bremen.de/peid=base-ftpamukkaleuniv:oai:gcris.pau.edu.tr:11499_52937&Exemplar=1&LAN=DE A1 Yazıcı, A A1 Şahin, N A1 Capkin, E A1 Karkucak, M A1 Durmaz, Y A1 Toprak, M A1 Ataman, Ş PB Springer Science and Business Media Deutschland GmbH YR 2023 K1 Hepatitis K1 Female K1 Hepatitis B Surface Antigens K1 Hepatitis B virus K1 Humans K1 Antiviral Agents K1 Arthritis K1 Psoriatic K1 Rheumatoid K1 Biological Factors K1 Biologic agents K1 Inflammatory arthritis K1 Viral reactivation K1 abatacept K1 adalimumab K1 antivirus agent K1 biological product K1 certolizumab pegol K1 corticosteroid K1 etanercept K1 golimumab K1 hepatitis B surface antigen K1 hydroxychloroquine K1 immunoglobulin G K1 infliximab K1 leflunomide K1 methotrexate K1 nonsteroid antiinflammatory agent K1 rituximab K1 salazosulfapyridine K1 tocilizumab K1 tofacitinib K1 ustekinumab K1 antirheumatic agent K1 biological factor K1 adult K1 aged K1 ankylosing spondylitis K1 Article K1 cohort analysis K1 controlled study K1 demographics K1 drug use K1 follow up K1 hepatitis B K1 hepatitis C JF Rheumatology International LK http://dx.doi.org/https://hdl.handle.net/11499/52937 DO https://hdl.handle.net/11499/52937 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)